Total Synthesis of Fasicularin and Lepadiformine
J. Am. Chem. Soc., Vol. 122, No. 19, 2000 4591
The second fractions afforded 22 (126 mg, 15%) as a white solid,
which was recrystallized from AcOEt-hexane to give colorless
needles: mp 101-102 °C; IR (KBr) 3319, 1732, 1669 cm-1; 1H NMR
(400 MHz, CDCl3) δ 1.18-1.97 (m, 9H), 2.12 (qd, J ) 12.9, 5.6 Hz,
1H), 2.26 (br d, J ) 13.2 Hz, 1H), 2.42 (A part of ABX, J ) 17.2,
12.5, 6.5 Hz, 1H), 2.54 (B part of ABX, J ) 17.2, 5.7, 1.7 Hz, 1H),
3.37 (s, 3H), 3.56 (A′ part of A′B′X, J ) 10.9, 4.5 Hz, 1H), 3.68 (B′
part of A′B′X, J ) 10.9, 7.3 Hz, 1H), 4.58 (m, 1H), 4.68 and 4.69
(ABq, J ) 6.5 Hz, 2H), 5.82 (A′′ part of A′′B′′X, J ) 10.4, 3.6 Hz,
1H), 6.35 (B′′ part of A′′B′′X, J ) 10.4, 1.8 Hz, 1H); 13C NMR (100.6
MHz, CDCl3) δ 20.6, 22.3, 22.5, 27.4, 32.1, 32.6, 38.3, 55.4, 61.5,
68.3, 78.3, 97.2, 123.6, 131.1, 164.7; EIMS m/z (relative intensity) 281
(M+, 1), 221 (12), 45 (100). Anal. Calcd for C15H23NO4: C, 64.04; H,
8.24; N, 4.98. Found: C, 64.07; H, 7.96; N, 4.99.
Figure 2. The X-ray structure (Chem3D representation) of synthetic
(()-lepadiformine hydrochloride [5‚HCl].
comparison with the spectra on natural lepadiformine kindly
provided by Professor Biard, revealing an exact match. This
finding strongly implies that the structure of natural lepadi-
formine reported in the literature3 was actually that of the
hydrochloride salt; this is understandable because the isolation
of the natural alkaloid was made by evaporation of an acidic
solution (MeOH-1 N HCl, 99:1) of the chromatography
fractions. These results therefore clearly indicate that structural
formula 3 involving the zwitterionic form originally assigned
to natural lepadiformine should be revised to 5 as shown.
In summary, the first total synthesis of tricyclic marine
alkaloids (()-fasicularin (2) and (()-lepadiformine (5) was
accomplished. The key common strategic element for the
synthesis is the stereocontrolled intramolecular hetero-Diels-
Alder reaction of an N-acylnitroso moiety to an exocyclic diene
with or without bromine substitution to control the syn-facial
or anti-facial selectivity, respectively, leading to the cis- or trans-
fused decahydroquinoline ring systems involving the simulta-
neous introduction of the nitrogenated quaternary center in a
single step. On further elaboration of the six-membered or five-
membered ring A, the trans-fused adduct provided either (()-
fasicularin (2) or (()-lepadiformine (5), and the cis-fused adduct
was converted into the originally proposed structure 4 of
lepadiformine in the nonzwitterionic form. The present inves-
tigation thus unambiguously established the relative stereo-
chemistry of lepadiformine, formerly assigned incorrectly, to
be 3R*,5S*,7aR*,11aR*.
Benzyl
(2E,4Z)-4-Bromo-4-{2-[3-(1,8-dimethyl-15-oxa-16-
szatetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaen-16-yl)-3-
oxopropyl]cyclohexylidene}-2-butenyl Ether (38). A solution of 36
(696 mg, 1.70 mmol) in CHCl3 (10 mL) was added dropwise to a
solution of 9,10-dimethylanthracene (897 mg, 4.26 mmol) and tetra-
propylammonium periodate (moistened with 10% water; 788 mg, 1.70
mmol) in CHCl3 (10 mL). The mixture was stirred for 1 h at room
temperature, quenched with 5% aqueous Na2S2O3 (5 mL), and extracted
with CHCl3 (2 × 50 mL). The organic phase was washed with brine,
dried (MgSO4), and concentrated in vacuo. Purification of the residue
by chromatography (hexane-AcOEt, 25:1) gave 38 (883 mg, 84%) as
a white solid, which was recrystallized from Et2O-hexane to give
colorless needles: mp 41-42 °C; IR (KBr) 1678 cm-1; 1H NMR (400
MHz, CDCl3) δ 1.36-1.80 (m, 9H), 1.88 (td, J ) 14.2, 4.4 Hz, 1H),
2.04 (ddd, J ) 16.3, 10.8, 4.9 Hz, 1H), 2.20 (s, 3H), 2.21 (m, 1H),
2.69 (s, 3H), 3.10 (m, 1H), 4.15 (dd, J ) 5.7, 1.3 Hz, 2H), 4.55 (s,
2H), 6.16 (dt, J ) 14.6, 5.7 Hz, 1H), 6.61 (d, J ) 14.6 Hz, 1H), 7.18-
7.50 (m, 13H).
(3R*,8aR*,12aR*)- and (3R*,8aS*,12aR*)-3-[(Benzyloxy)methyl]-
1-bromo-8,8a,9,10,11,12-hexahydro-3H-[1,2]oxazino[3,2-j]quinolin-
6(7H)-one (39 and 40). A solution of 38 (876 mg, 1.43 mmol) in
benzene (450 mL) was heated at reflux with stirring for 3 h. After
being cooled to room temperature, the solution was concentrated in
vacuo and subjected to chromatography eluting with hexane-AcOEt
(25:1) to give 437 mg (75%) of an inseparable 5.5:1 mixture (based
on 1H NMR analysis) of 39 and 40 as a colorless oil: IR (neat) 1790,
1
1683 cm-1; H NMR (400 MHz, CDCl3) δ 1.16-1.66 (m, 6H), 1.78
(br d, J ) 10.4 Hz, 1H), 1.87 (tdd, J ) 13.6, 6.2, 3.5 Hz, 2H), 2.29-
2.39 and 2.41 (m, and, d, J ) 6.1 Hz, respectively, total 2H in 5.5:1
ratio), 2.50 (m, 1H), 2.57 and 2.62 (dd, J ) 13.5, 6.8 Hz, each, total
1H in 5.5:1 ratio), 3.60 and 3.58 (A part of ABX, J ) 9.9, 7.0 Hz, and
A′ part of A′B′X, J ) 9.8, 7.8 Hz, respectively, total 1H in 5.5:1 ratio),
3.84 and 3.90 (B part of ABX, J ) 9.9, 5.8 Hz, and B′ part of A′B′X,
J ) 9.7, 5.8 Hz, respectively, total 1H in 5.5:1 ratio), 4.54 and 4.56
(1/2ABq, J ) 11.8 Hz, each, total 1H in 5.5:1 ratio), 4.60 and 4.62
(1/2ABq, J ) 11.8 Hz, each, total 1H in 5.5:1 ratio), 4.61 (m, 1H),
6.18 and 6.32 (d, J ) 3.2 Hz, and, d, J ) 2.6 Hz, respectively, total
1H in 5.5:1 ratio), 7.27-7.35 (m, 5H); 13C NMR (100.6 MHz, CDCl3)
δ 21.4 and 21.3 (1 carbon in 5.5:1 ratio), 22.5 and 24.5 (1 carbon
in 5.5:1 ratio), 25.0 and 25.2 (1 carbon in 5.5:1 ratio), 25.8 and 27.9
(1 carbon in 5.5:1 ratio), 29.9 and 33.9 (1 carbon in 5.5:1 ratio), 32.3
and 38.9 (1 carbon in 5.5:1 ratio), 37.2 and 44.7 (1 carbon in 5.5:1
ratio), 66.8 and 64.9 (1 carbon in 5.5:1 ratio), 71.7 and 69.5 (1 car-
bon in 5.5:1 ratio), 73.4 and 72.0 (1 carbon in 5.5:1 ratio), 81.7 and
80.9 (1 carbon in 5.5:1 ratio), 127.7, 127.8 (2C), 128.4 (2C), 129.5,
130.5, 138.0, 169.0 and 169.2 (1 carbon in 5.5:1 ratio); EIMS m/z
Experimental Section30
Preparation of (3R*,8aS*,12aR*)- and (3R*,8aR*,12R*)-2-
[(Methoxymethoxy)methyl]-8,8a,9,10,11,12-hexahydro-3H-[1,2]ox-
azino[3,2-j]quinolin-6(7H)-one (21 and 22): Typical Procedure. To
an ice-cooled, vigorously stirred emulsion of 19 (824 mg, 2.91 mmol)
dispersed in a 5:1 mixture (13 mL) of water and MeOH was added
solid tetrabutylammonium periodate (2.52 g, 5.11 mmol). After being
stirred at 0 °C for 20 min, the mixture was quenched with 10% aqueous
Na2S2O3 (50 mL) and extracted with CHCl3 (2 × 500 mL). The
combined organic extracts were washed with water, dried (MgSO4),
and concentrated in vacuo to give an oil. HPLC analysis (hexane-2-
propanol, 5:1) of the crude product showed the formation of a 4.5:1
mixture of the cycloadducts 21 and 22, which was separated by
chromatography (CHCl3-acetone, 9:1). The first fractions afforded 21
(565 mg, 69%) as a colorless oil, which solidified on storage in a
refrigerator. Recrystallization from hexane afforded colorless needles:
mp 28-29 °C; IR (KBr) 3445, 1679 cm-1; 1H NMR (400 MHz, CDCl3)
δ 1.23-1.88 (m, 10H), 2.41 (dt, J ) 12.9, 3.1 Hz, 1H), 2.45-2.51 (m,
2H), 3.39 (s, 3H), 3.58 (dd, J ) 10.6, 6.1 Hz, 1H), 3.89 (m, 1H), 4.62
(tt, J ) 6.6, 2.7 Hz, 1H), 4.68 and 4.74 (ABq, J ) 6.4 Hz, 2H), 5.88
(A part of ABX, J ) 10.6, 2.4 Hz, 1H), 6.36 (B part of ABX, J )
10.6, 2.5 Hz, 1H); 13C NMR (100.6 MHz, CDCl3) δ 22.1, 24.7, 25.6,
27.1, 34.3, 38.2, 43.7, 55.4, 62.4, 69.9, 79.3, 97.0, 125.8, 130.6, 168.3;
EIMS m/z (relative intensity) 281 (M+, 0.4), 45 (100); HRMS calcd
for C15H23NO4 (M+) 281.1627, found 281.1617.
(relative intensity) 408 (M+ + 3, 6), 406 (M+ + 1, 6), 326 (M+
-
Br, 11), 268 (12), 205 (10), 176 (13), 91 (100). Anal. Calcd for
C20H24NO3Br: C, 59.12; H, 5.95; N, 3.45. Found: C, 59.09; H, 6.08;
N, 3.33.
Acknowledgment. We are grateful to Professor J. F. Biard
(Universite´ de Nantes) for a sample of natural lepadiformine
and Professor D. J. Faulkner (Scripps Institution of Oceanog-
raphy, University of California at San Diego) and Dr. J. Chan
(SmithKline Beecham Pharmaceuticals) for proving authentic
(30) See Supporting Information for General Procedures.